Stefan Kornigg

Drugging an undruggable pocket on KRAS

Dirk Kessler, Michael Gmachl, Andreas Mantoulidis et al. · Proceedings of the National Academy of Sciences · 2019 · 434 citations · Full text

Medicine, Molecular Biology, Oncology +15

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Laetitia J. Martin, Manfred Koegl, Gerd Bader et al. · Journal of Medicinal Chemistry · 2016 · 224 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

A 3D‐Printed Open Access Photoreactor Designed for Versatile Applications in Photoredox‐ and Photoelectrochemical Synthesis**

Florian Schiel, Christoph Peinsipp, Stefan Kornigg et al. · ChemPhotoChem · 2021 · 60 citations · Full text

Natural Sciences, Chemical Engineering, Chemistry +14

Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling

Birgit Wilding, Dirk Scharn, Dietrich Böse et al. · Nature Cancer · 2022 · 53 citations

Medicine, Medicinal Chemistry, Oncology +15

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines

Katharina Ehrenhöfer-Wölfer, Teresa Puchner, Cornelia Schwarz et al. · Scientific Reports · 2019 · 51 citations · Full text

Life Sciences, Molecular Biology, Oncology +17